MEDTRONIC PUERTO RICO OPERATIONS CO. PARADIGM REAL-TIME INSULIN INFUSION PUMP MMT-754LWWS; PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR
|
Back to Search Results |
|
Model Number MMT-754LWWS |
Device Problems
Break (1069); Detachment of Device or Device Component (2907)
|
Patient Problems
Hyperglycemia (1905); Nausea (1970)
|
Event Date 09/21/2022 |
Event Type
Injury
|
Event Description
|
Information received by medtronic indicated that the customer experienced hyperglycemia and customer reporting symptoms like nausea.The blood glucose value at the time of the event was 400mg/dl.The customer also stated that they observed damaged in drive support cap and battery compartment.No further patient complications were reported.Troubleshooting was performed, and advised the customer to discontinue the use of insulin pump.The insulin pump will be returned for analysis.
|
|
Manufacturer Narrative
|
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.The insulin pump involved in this event is the paradigm real-time veo insulin infusion pump, which is not marketed in the united states.However, the device is similar to the paradigm real-time insulin infusion pump, which is marketed in the united states.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Additional information has been received which was not included with the initial report.The information has been provided in section h10 with this report.Customer returned insulin pump for an alleged insulin pump high bgs and case damage.On event date september 21, 2022.Insulin pump passed displacement test, rewind test, prime/seating test, basic occlusion test, force sensor test, occlusion test, sleep current measurement, active current measurement and self test.Insulin pump was monitored and functioning properly.Insulin pump passed the dat at 0.08850 inches.Tested with a test p-cap and the test p-cap locked in place properly.Insulin pump care link and insulin pump history was download successfully.Insulin pump perform visual inspection and insulin pump received with cracked battery tube threads, minor scratched lcd window and missing end cap sticker.Insulin pump passed required testing.Confirmed cracked battery compartment.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The device was returned for analysis.
|
|
Search Alerts/Recalls
|
|
|